G protein-coupled receptor (GPR)119, predominantly expressed in the small intestine and islet β-cells, has been recognized as a promising therapeutic target for diabetes (Overton et al., 2008; Bahirat et al., 2017). The gene discussed is GPR119; the disease is diabetes mellitus.